7:45 – 8:30 am |
General Check-in & Networking Breakfast |
|
Sponsored by:
|
8:30 – 8:45 am |
Welcome & Chairman’s 2016 Year in Review |
|
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus
|
8:45 – 10:30 am |
Anterior Segment Company Showcase |
|
Co-Moderated By:
Christy Shaffer, PhD, General Partner – Hatteras Venture Partners
Catherine Truitt, Head, Search and Evaluation – Alcon
Company Presentations
- 8:45 – 8:52 | Avedro | Rajesh K. Rajpal, MD, Chief Medical Officer
- 8:52 – 8:59 | Z Lens | Paul Beer, MD, Founder & CEO
- 8:59 – 9:06 | PowerVision | Barry Cheskin, Co-Founder, President & CEO
- 9:06 – 9:13 | Novaliq GmbH | Bernhard Günther, CEO & Managing Director
- 9:13 – 9:20 | Mynosys Cellular Devices | John Hendrick, President & CEO
- 9:20 – 9:27 | ReVision Optics | John Kilcoyne, President & CEO
- 9:27 – 9:34 | AcuFocus | Al Waterhouse, President
- 9:34 – 9:41 | Encore Vision | Bill Burns, President & CEO
- 9:41 – 9:48 | Mati Therapeutics | Bob Butchofsky, Founder & CEO
- 9:48 – 9:55 | Envisia Therapeutics | Benjamin Yerxa, PhD, President
- 9:55 – 10:02 | Ivantis | Dave Van Meter, President & CEO
- 10:02 – 10:09 | Sensimed AG | David Bailey, CEO
- 10:09 – 10:16 | TearScience | Joseph Boorady, President & CEO
- 10:16 – 10:23 | LacriScience | Chris Geddes, PhD, Chief Biomedical/Plasmonics Consultant
- 10:23 – 10:30 | SightLife | Monty Montoya, CEO
|
10:30 – 11:00 am |
Morning Networking & Refreshment Break |
|
Sponsored by:
|
11:00 am – 12:38 pm |
Posterior Segment Company Showcase |
|
Co-Moderated By:
Peggy Hawkins, Business Development & Venture Management – Santen
Tom Cordaro, Head, Ophthalmology Pipeline – Bayer
Company Presentations
- 11:00 – 11:07 | Aura Biosciences | Elisabet de los Pinos, CEO
- 11:07 – 11:14 | AGTC | Sue Washer, President & CEO
- 11:14 – 11:21 | Clearside Biomedical | Daniel White, President & CEO
- 11:21 – 11:28 | Alimera Sciences | Dan Myers, CEO
- 11:28 – 11:35 | Aerpio Therapeutics | Joseph Gardner, President & CEO
- 11:35 – 11:42 | Allegro Ophthalmics | Vicken Karageozian, MD, President & Chief Medical Officer
- 11:42 – 11:49 | Ocular Therapeutix | Amar Sawhney, PhD, President, CEO & Chairman
- 11:49 – 11:56 | Graybug Vision | Jeffrey Cleland, PhD, President & CEO
- 11:56 – 12:03 | PanOptica | Paul Chaney, Co-Founder, President & CEO
- 12:03 – 12:10 | Opthea | Megan Baldwin, PhD, CEO & Managing Director
- 12:10 – 12:17 | Ohr Pharmaceutical | Jason Slakter, CEO
- 12:17 – 12:24 | Tracery Ophthalmics inc | Shelley Boyd, MD, President & CEO
- 12:24 – 12:31 | Apellis Pharmaceuticals | Cedric Francois, MD, PhD, CEO
- 12:31 – 12:38 | Notal Vision | Quinton Oswald, CEO
|
12:38 – 12:43 pm |
Private Funding Trends Presentation |
|
Jonathan Norris, Managing Director – SVB
|
12:43 – 1:25 pm |
Networking Lunch |
|
Sponsored by:
|
1:25 – 1:50 pm |
OIS Industry Tribute to Allergan |
|
Interviewed By:
William J. Link, PhD, Managing Director – Versant Ventures
Award Recipients:
Gavin Herbert, Founder
David Pyott, Former CEO
|
1:50 – 2:20 pm |
BUILDING A GLOBAL OPHTHALMIC FRANCHISE |
|
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus
Participants:
Robert Dempsey, Franchise Head, Ophthalmics – Shire
Jerry St. Peter, VP & Head, Sun Ophthalmics – Sun Pharmaceutical Industries
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
Calvin Roberts, MD, SVP & Chief Medical Officer – Bausch + Lomb
Jim Mazzo, Global President Ophthalmic Devices – Carl Zeiss Meditec
|
2:20 – 2:50 pm |
Afternoon Networking & Refreshment Break |
|
Sponsored by:
|
2:50 – 2:55 pm |
Ophthalmic Innovation 2016 – “A View from the AAO” |
|
David Parke, II, MD, CEO – American Academy of Ophthalmology (AAO)
|
2:55 – 3:00 pm |
Ophthalmic Innovation 2016 – “A View from the NEI” |
|
Mala Dutta, PhD, Lead, Office of Translational Research, National Eye Institute – NIH
|
3:00 – 3:05 pm |
A View of the Public Ophthalmology Market & Exit Trends |
|
Joe Gilliam, Managing Director, Healthcare Investment Banking – J.P. Morgan Securities
|
3:05 – 3:10 pm |
Introduction of the OIS Index |
|
Michael Lachman, Founder – EyeQ Research
|
3:10 – 3:58 pm |
Public Device & BioPharma Ophthalmology Company Showcase |
|
Moderated By:
Tom Salemi, Content Director – Healthegy
Company Presentations
- 3:10 – 3:18 | Aerie Pharmaceuticals | Vicente Anido Jr., PhD, CEO & Chairman
- 3:18 – 3:26 | Inotek Pharmaceuticals | David Southwell, President & CEO
- 3:26 – 3:34 | QLT | David Saperstein, MD, Chief Medical Advisor
- 3:34 – 3:42 | Adverum Biotechnologies | Samuel B. Barone, MD, SVP, Clinical Development
- 3:42 – 3:50 | pSivida | Nancy Lurker, President & CEO
- 3:50 – 3:58 | Omeros | Leonard M. Blum, Chief Business & Commercial Officer
|
3:58 – 4:30 pm |
Innovative Financing Options in Ophthalmology |
|
Moderated By:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Participants:
Sean Ianchulev, MD, MPH, Clinical Associate Professor – UCSF
Laurent Attias, Head of Strategy, BD&L and M&A – Alcon
Nir Ellenbogen, Managing Director – Eye-Lens Pte Ltd
Jeffry Weinhuff, Managing Partner – Visionary Venture Fund
Patricia Zilliox, PhD, Chief Drug Development Officer – Foundation Fighting Blindness
|
4:30 – 5:10 pm |
Masters of the Industry |
|
Moderated By:
Jim Mazzo, Global President Ophthalmic Devices – Carl Zeiss Meditec
Participants:
Flemming Ornskov, MD, CEO – Shire
Mike Ball, CEO – Alcon
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
William J. Link, PhD, Managing Director – Versant Ventures
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec
William Meury, Chief Commercial Officer – Allergan
|
5:10 – 5:15 pm |
Closing Remarks |
|
William J. Link, PhD, Managing Director – Versant Ventures
|
5:15 – 6:15 pm |
Networking Reception |
|
Sponsored by:
|